Company Overview
About Hims & Hers Health
Hims & Hers Health is a telehealth and wellness platform offering personalized treatment plans and prescription medications for conditions including hair loss, erectile dysfunction, weight management, skincare, and mental health. Founded in 2017 and headquartered in San Francisco, Hims & Hers went public via SPAC merger in January 2021 and has grown into a $1B+ revenue publicly traded health company. The platform connects patients with licensed providers asynchronously and ships prescription treatments directly to homes, eliminating the friction of in-person doctor visits for lifestyle health conditions.
Business Model & Competitive Advantage
The company generated $872 million in revenue in 2024, growing over 40% year-over-year, driven significantly by its GLP-1 weight loss program which launched prescriptions for compounded semaglutide as Ozempic and Wegovy supply shortages created massive demand. Hims & Hers enrolled hundreds of thousands of weight loss subscribers in 2024, fundamentally changing its revenue mix and growth trajectory. The company serves over 2 million subscribers across its product lines.
Competitive Landscape 2025–2026
In 2025, Hims & Hers faces regulatory uncertainty around compounded GLP-1 medications as the FDA has moved to restrict compounding once brand-name shortages are resolved. The company has been diversifying its weight management portfolio and investing in its broader personalized health platform. Hims & Hers continues to expand its mental health (therapy, psychiatry) and women's health offerings while navigating the complex regulatory landscape of telehealth prescribing. Revenue is projected at $1.2B+ in 2025 as the company deepens patient relationships beyond single-condition treatments.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Hims & Hers Health is an emerging player bringing innovative solutions to the Healthcare market.
Massive User Base
Trusted by 2M worldwide, demonstrating broad market appeal and proven reliability.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
S2
S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Hims & Hers Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Hims & Hers Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Hims & Hers Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Hims & Hers Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →